Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.16.8) and a change in status from 'Recruiting' to 'Active, not recruiting'. Additionally, the date has been updated from 2025-06-11 to 2025-07-23.SummaryDifference2%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.3%
- Check18 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check25 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check47 days agoChange DetectedThe web page has updated its version from v2.16.2 to v2.16.3 and changed the date from 2025-05-11 to 2025-06-11.SummaryDifference0.6%
Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.